The company is a provider of integrated clinical research technology solutions to pharmaceutical biotechnology and medical device companies and other organizations.


Updates from The Motley Fool

Latest updates on Biocept from Fool.com.

There is no available coverage of Biocept at this time.



Stock Performance

View Interactive BIOC Charts
Sponsored by

Key Data Points

Primary metrics and data points about Biocept.
Current Price: $1.21
Prev Close: $1.18
Open: $1.22
Bid: $1.19
Ask: $1.22
Day's Range: $1.17 - $1.22
52wk Range: $0.74 - $3.39
Volume: 384,436
Avg Vol 368,497
Market Cap: $37M
P/E (ttm): -0.55
EPS (ttm): ($2.16)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Biocept.
CAPS Rating 1 out of 5
 
12 Outperform
17 Underperform
CAPS All Stars
 
1 Outperform
15 Underperform

How do you think Biocept will perform against the market?



You pick for Biocept is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


Business Summary

Industry, sector and description for Biocept.

The company is a provider of integrated clinical research technology solutions to pharmaceutical biotechnology and medical device companies and other organizations.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Healthcare IT